Interferons in relapsing remitting multiple sclerosis: a systematic review.

  title={Interferons in relapsing remitting multiple sclerosis: a systematic review.},
  author={Graziella Filippini and Luca Maria Munari and Barbara Incorvaia and George Cornell Ebers and Chris Polman and R D'amico and George P. Rice},
  volume={361 9357},
BACKGROUND Recombinant interferons have been approved by many national regulatory agencies for treatment of relapsing remitting multiple sclerosis, but widespread discussion continues about their true effectiveness, benefits, side-effects, and costs. METHODS With the Cochrane Collaboration methodology, we reviewed all published, randomised, placebo-controlled trials of recombinant interferons undertaken in patients with relapsing remitting multiple sclerosis between 1993 and 2002. Our primary… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 106 extracted citations


Publications referenced by this paper.
Showing 1-10 of 38 references

Quality of life as a predictor for change in disability in MS

  • G Rice, G Ebers
  • Neurology
  • 2000

A longitudinal study of brain atrophy in relapsing multiple sclerosis

  • LD Jacobs, RW Beck, JH Simon
  • Neurology
  • 1999

Interferon - alpha 2 a reduces MRI disease activity in relapsing - remitting multiple sclerosis

  • MW Nortvedt, T Riise, KM Myhr
  • Neurology
  • 1999

Similar Papers

Loading similar papers…